PREVENTION OF REFRACTORINESS AND HLA-ALLOIMMUNIZATION USING FILTERED BLOOD PRODUCTS

被引:0
|
作者
SNIECINSKI, I
ODONNELL, MR
NOWICKI, B
HILL, LR
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1402 / 1407
页数:6
相关论文
共 50 条
  • [31] PREVENTION OF REFRACTORINESS TO PLATELET TRANSFUSION BY THE USE OF NON-LEUKOCYTE DEPLETED STORED-BLOOD PRODUCTS
    DEWOLF, JTM
    WESTERTERP, A
    HALIE, MR
    BLOOD, 1994, 84 (10) : A667 - A667
  • [32] COMPARISON OF FILTERED BLOOD (FB) TO SERONEGATIVE BLOOD PRODUCTS (SB) FOR PREVENTION OF CYTOMEGALOVIRUS (CMV) INFECTION AFTER MARROW TRANSPLANT
    BOWDEN, RA
    CAYS, M
    SCHOCH, G
    SAYERS, M
    SLICHTER, SJ
    WELK, K
    HAAKE, R
    MCCULLOUGH, J
    WEISDORF, D
    MILLER, W
    BLOOD, 1993, 82 (10) : A204 - A204
  • [33] PREVENTION OF HLA ALLOIMMUNIZATION - ROLE OF LEUKOCYTE DEPLETION AND UV-B IRRADIATION
    SNYDER, EL
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1990, 63 (05): : 419 - 427
  • [34] BLOOD COMPONENT TREATMENT AND HLA ALLOIMMUNIZATION RATE OF PATIENTS WITH DISEASES OF HEMATOPOIESIS
    SCHNEIDER, W
    SCHNAIDT, M
    SCHUNTER, F
    SUGG, U
    KLEMENT, H
    BLUT, 1982, 45 (01): : 60 - 60
  • [35] Genomewide association study of HLA alloimmunization in previously pregnant blood donors
    Seielstad, Mark
    Page, Grier P.
    Gaddis, Nathan
    Lanteri, Marion
    Lee, Tzong-Hae
    Kakaiya, Ram
    Barcellos, Lisa F.
    Criswell, Lindsey A.
    Triulzi, Darrell
    Norris, Philip J.
    Busch, Michael P.
    TRANSFUSION, 2018, 58 (02) : 402 - 412
  • [36] HLA SENSITIZATION FROM TRANSFUSIONS IN PATIENTS WITH RED BLOOD CELL ALLOIMMUNIZATION
    Katalinic, Natasa
    Caser, Linda
    Vukelic-Damijani, Nada
    Ivankovic, Edita
    Fucak, Marina
    Kurtovic, Helena
    Mujic, Aida
    Crnic, Tajana
    Curkovic, Milena
    Balen, Sanja
    TISSUE ANTIGENS, 2014, 84 (01): : 114 - 114
  • [37] Recent Developments and Future Directions of Alloimmunization to Transfused Blood Products
    Zimring, James C.
    CLINICS IN LABORATORY MEDICINE, 2010, 30 (02) : 467 - +
  • [38] Persistence of Lymphocytotoxic Antibodies in Patients in the Trial to Reduce Alloimmunization to Platelets: Implications for Using Modified Blood Products
    Slichter, Sherrill J.
    Bolgiano, Douglas
    Kao, Kuo-Jang
    Kickler, Thomas S.
    McFarland, Janice
    McCullough, Jeffrey
    Woodson, Robert
    TRANSFUSION MEDICINE REVIEWS, 2011, 25 (02) : 102 - 110
  • [39] PREVENTION OF PRIMARY HLA CLASS-I ALLOIMMUNIZATION WITH LEUKOCYTE-POOR BLOOD COMPONENTS PRODUCED WITHOUT THE USE OF PLATELET FILTERS
    TENHAAFT, MA
    VANDENBERGLOONEN, PM
    VANRHENEN, DJ
    VOX SANGUINIS, 1992, 63 (04) : 257 - 261
  • [40] Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection - Response
    Bowden, RA
    Slichter, S
    Sayers, M
    Weisdorf, D
    Fisher, L
    BLOOD, 1996, 87 (11) : 4910 - 4911